vimarsana.com

Page 10 - Headache Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.